CLEMENTI, EMILIO GIUSEPPE IGNAZIO
CLEMENTI, EMILIO GIUSEPPE IGNAZIO
Dipartimento di Scienze Biomediche e Cliniche
Antipsychotics and dietary interventions: Pharmacodynamics, pharmacokinetics, and synergisms in therapy
2025 C. Perrotta, C. Carnovale, M. Pozzi, C. De Palma, D. Cervia, M. Nobile, E. Clementi
NAT2 Acetylation Status Predicts Hepatotoxicity During Antituberculosis Therapy: Cumulative Risk Analysis of a Multiethnic Cohort
2025 M. Schiuma, S. Dinegro, V. Battini, A. Torre, A. Covizzi, A. Civati, M. Galimberti, I. Mariani, G. Mosini, C. Carnovale, A. Riva, A. Gori, S. Antinori, E. Clementi, S. Radice, S. Cheli
Immunosenescence in skeletal muscle: The role-play in cancer cachexia chessboard
2025 M. Giovarelli, E. Mocciaro, C. Carnovale, D. Cervia, C. Perrotta, E. Clementi
The SIRT1 activator SRT2104 exerts exercise mimetic effects and promotes Duchenne muscular dystrophy recovery
2025 M. Giovarelli, S. Zecchini, S.R. Casati, L. Lociuro, O. Gjana, L. Mollica, E. Pisanu, H.D. Mbissam, O. Cappellari, C. De Santis, A. Arcari, A. Bigot, G. Clerici, E. Catalani, S. Del Quondam, A. Andolfo, C. Braccia, M.G. Cattaneo, C. Banfi, D. Brunetti, E. Mocciaro, A. De Luca, E. Clementi, D. Cervia, C. Perrotta, C. De Palma
Exploring the impact of co-exposure timing on drug-drug interactions in signal detection through spontaneous reporting system databases: a scoping review
2024 M. Cocco, C. Carnovale, E. Clementi, M.A. Barbieri, V. Battini, M. Sessa
NAT2 Slow Acetylator Phenotype as a Significant Risk Factor for Hepatotoxicity Caused by Antituberculosis Drugs: Results From a Multiethnic Nested Case-Control Study
2024 S. Cheli, A. Torre, M. Schiuma, C. Montrasio, A. Civati, M. Galimberti, V. Battini, I. Mariani, G. Mosini, C. Carnovale, S. Radice, E. Clementi, A. Gori, S. Antinori
PPP exposure models for 3‐D orchards considering spraying technologies in Southern Europe
2024 G. Azimonti, P.C. Adell, E. Clementi, K.P. Ferentinos, C.G. Figueroa, M. Grella, M. Luini, P. Marucco, E. Mozzanini, M. Resecco, L. Tosti
Timing Matters: A Machine Learning Method for the Prioritization of Drug–Drug Interactions Through Signal Detection in the FDA Adverse Event Reporting System and Their Relationship with Time of Co-exposure
2024 V. Battini, M. Cocco, M.A. Barbieri, G. Powell, C. Carnovale, E. Clementi, A. Bate, M. Sessa
Relevance of pharmacogenetic analyses and therapeutic drug monitoring of antidepressants for an individualized treatment of peripartum psychopathology
2024 A. Colombo, R. Cafaro, I. Di Bernardo, M. Mereghetti, L. Cerolini, L. Giacovelli, F. Giorgetti, S. Vanzetto, N. Girone, V. Savasi, I. Cetin, E. Clementi, M.F. Bosi, V. Caterina, B. Dell’Osso
Low-dose aspirin and risk of anaemia in older adults: insights from a Danish register-based cohort study
2024 M.A. Barbieri, D.S. Peker, M.G.S. Askar, V. Battini, A. Abate, C. Carnovale, E. Clementi, R. Ofori-Asenso, E. Spina, M. Pareek, K. Kragholm, C. Torp-Pedersen, M. Sessa
New data-driven method to predict the therapeutic indication of redeemed prescriptions in secondary data sources: a case study on antiseizure medications users aged ≥65 identified in Danish registries
2024 I. Mahmoud, V. Battini, C. Carnovale, E. Clementi, K. Kragholm, M. Sessa
Comparing major and mild cognitive impairment risks in older type-2 diabetic patients: a Danish register-based study on dipeptidyl peptidase-4 inhibitors vs. glucagon-like peptide-1 analogues
2024 V. Battini, M.A. Barbieri, C. Carnovale, E. Spina, E. Clementi, M. Sessa
Oral administration of plumbagin is beneficial in in vivo models of Duchenne muscular dystrophy through control of redox signaling
2024 D. Cervia, S. Zecchini, L. Pincigher, P. Roux-Biejat, C. Zalambani, E. Catalani, A. Arcari, S. Del Quondam, K. Brunetti, R. Ottria, S. Casati, C. Vanetti, M.C. Barbalace, C. Prata, M. Malaguti, S.R. Casati, L. Lociuro, M. Giovarelli, E. Mocciaro, S. Falcone, C. Fenizia, C. Moscheni, S. Hrelia, C. De Palma, E. Clementi, C. Perrotta
Updated Considerations for the Immunopharmacological Aspects of the “Talented mRNA Vaccines”
2023 C. Perrotta, C. Fenizia, C. Carnovale, M. Pozzi, D. Trabattoni, D. Cervia, E. Clementi
Umbrella Review: Association Between Antipsychotic Drugs and Metabolic Syndrome Hallmarks in Children and Adolescents
2023 C. Carnovale, V. Battini, C. Santoro, M.P. Riccio, S. Carucci, M. Nobile, P. Formisano, C. Bravaccio, A. Zuddas, E. Clementi, M. Pozzi, S. Pisano
The potential effect of metformin on cognitive and other symptom dimensions in patients with schizophrenia and antipsychotic-induced weight gain: a systematic review, meta-analysis, and meta-regression
2023 V. Battini, G. Cirnigliaro, R. Leuzzi, E. Rissotto, G. Mosini, B. Benatti, M. Pozzi, M. Nobile, S. Radice, C. Carnovale, B. Dell'Osso, E. Clementi
Two Years of Active Pharmacovigilance Surveillance and Therapeutic Reconciliation in Frail Populations: The MEAP 3.0 Study
2023 A. Bombelli, G. Guarnieri, N. Lombardi, M.G. Sullo, E. Spina, G. Crescioli, C. Rafaniello, G. Cicala, V. Marangon, R. Folchino, S. Vecchio, G. Mosini, S. Radice, E. Clementi
Neuroprotective role of plumbagin on eye damage induced by high-sucrose diet in adult fruit fly Drosophila melanogaster
2023 E. Catalani, S. Del Quondam, K. Brunetti, A. Cherubini, S. Bongiorni, A.R. Taddei, S. Zecchini, M. Giovarelli, C. De Palma, C. Perrotta, E. Clementi, G. Prantera, D. Cervia
Exposure to environmental pollutants and attention-deficit/hyperactivity disorder: an overview of systematic reviews and meta-analyses
2023 E. Rosi, A. Crippa, M. Pozzi, S. De Francesco, M. Fioravanti, M. Mauri, M. Molteni, L. Morello, L. Tosti, F. Metruccio, E. Clementi, M. Nobile
Psychiatric and non-psychiatric drugs causing false-positive amphetamines urine test in psychiatric patients: a pharmacovigilance analysis using FAERS
2023 V. Battini, G. Cirnigliaro, L. Giacovelli, M. Boscacci, S. MASSARA MANZO, G. Mosini, G. Guarnieri, M. Gringeri, B. Benatti, E.G.I. Clementi, D. Bernardo, C. Carnovale